Psoriasis Clinical Trial
Long Term Safety and Efficacy Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis
Summary
The objective of this study is to evaluate the safety and efficacy of up to 26 weeks of treatment with calcitriol 3 mcg/g ointment when used twice daily, without occlusion, to treat pediatric subjects (2 to 16 years and 11 months of age) with mild to moderate plaque psoriasis.
Eligibility Criteria
Inclusion Criteria:
Male or female 2 to 16 years and 11 months of age
Clinical diagnosis of stable mild to moderate plaque psoriasis
Exclusion Criteria:
Other forms of psoriasis
Hypercalcemia
Past history of kidney stones
Vitamin D deficiency
Other concomitant dermatological disease
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 16 Locations for this study
Fort Smith Arkansas, 72916, United States
Rogers Arkansas, 72758, United States
Burbank California, 91505, United States
Tampa Florida, 33612, United States
Carmel Indiana, 46032, United States
Indianapolis Indiana, 46256, United States
New York New York, 10467, United States
Arlington Texas, 76011, United States
Gent , 9000, Belgium
Markham Ontario, L3P1X, Canada
Montreal Quebec, H3T1C, Canada
Berlin , 10117, Germany
Dresden , 01307, Germany
Mainz , 55131, Germany
Padova , 35128, Italy
Parma , 43126, Italy
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.